Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Total Pharmacy Services, Inc.
483
•Total Pharmacy Services, Inc.•May 22, 2013

Total Pharmacy Services, Inc. – FDA 483, May 22, 2013

Record Details

The FDA Form 483 details numerous deficiencies at a facility producing sterile drug products from non-sterile components. Aseptic processing areas lack adequate environmental monitoring, with smoke studies not dynamic or videotaped, and surface/air monitoring of ISO 5 environments, along with personnel fingertip sampling, not conducted daily. Pressure differentials have not been monitored since July 25, 2012.

Sterilization processes are not validated; specifically, a redacted filter used for injectable products lacks qualification for bacterial retention and physical/chemical compatibility, and integrity testing documentation is absent. Personnel wear non-sterile cloth gowns and face masks. Procedures for preventing microbiological contamination are deficient: media fills do not simulate actual production, and employees were observed placing materials directly on ISO 5 surfaces without sanitization and resting non-sterile gown-covered arms on the work surface.

Cleaning and disinfection procedures are inadequate; a sporicidal agent's use frequency is not specified or documented, and non-sterile wipes are used in the ISO 5 environment. Each batch of sterile drug product is not tested for sterility or endotoxin. Potency analysis is not conducted on any injectable product. There is no written stability program, lacking scientific data for the three-month beyond-use date assigned to all injectable sterile products.

Raw material testing is insufficient; no additional testing is performed, and suppliers are not qualified to verify Certificates of Analysis. Complaint handling procedures are deficient: a complaint from April 201

Company
Total Pharmacy Services, Inc.
Inspection date
May 22, 2013
Product type
Drugs
Office
New Orleans District Office
Person
  • Claire M. Minden (CO CDER OMQ)
View Company Profile

ID · c6e4cedd-4dd4-4412-8741-ef378114f2d0

Violation Codes5
21 CFR 211.22(a)21 CFR 331(c)21 CFR 210.1(b)21 CFR 211.46(b)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Total Pharmacy Services, Inc.
  • 483 - 2014-09-30September 30, 2014
  • WARNING_LETTER - 2013-05-22May 22, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Total Pharmacy Services, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.